Keyword: South San Francisco
The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.
Charles River has penned “early 2020” for the opening of its Charles River Accelerator and Development Lab (aka CRADL) in South San Francisco.
Mission Bio is staffing up following a $30 million round and a new deal with LabCorp and its Covance drug development business.
Amgen’s head of translational medicine, Aarif Khakoo, M.D., is making the jump to Calico Life Sciences to head up drug development.
AbbVie has signed on to be the first tenant at a new biotech campus in South San Francisco.
Beacon Capital's incubator will offer up to $50 million in seed funding, as well as office and lab space.
Amgen is moving more than 100 R&D jobs from its headquarters to facilities in Cambridge, Massachusetts, and San Francisco, California.